BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 332359)

  • 21. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant lymphomas in Korea.
    Chi JG; Shin SS; Ahn GH; Lee SK
    Jpn J Clin Oncol; 1985 Dec; 15(4):653-9. PubMed ID: 4094098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gastric lymphomas and pseudolymphomas].
    Chabloz R; Givel JC; Saraga P; Saegesser F
    Helv Chir Acta; 1980 Dec; 47(5):547-53. PubMed ID: 7204076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
    Teske E; Wisman P; Moore PF; van Heerde P
    Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic classification as a prognostic criterion for canine lymphosarcoma.
    Weller RE; Holmberg CA; Theilen GH; Madewell BR
    Am J Vet Res; 1980 Aug; 41(8):1310-4. PubMed ID: 6893792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of immunophenotype in diffuse non-Hodgkin's lymphoma: with special emphasis on the clinical characteristics of T-cell lymphoma].
    Chubachi A; Miura AB; Takatsu H; Yamaguchi A; Nishimura S; Nakayama Y; Akihama T; Miura S; Saitoh M; Watanuki T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1303-9. PubMed ID: 2069401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Description of the cells from the lymph nodes of patients with non-Hodgkin's lymphoma according to some B- and T-cell characteristics.
    Stathopoulos G; Papamichail M; Holborow EJ; Davies AJ
    Br J Exp Pathol; 1977 Feb; 58(1):95-100. PubMed ID: 300026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
    Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
    Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The usefulness of cell surface markers in predicting the prognosis of non-Hodgkin's lymphomas.
    Baird S
    Crit Rev Clin Lab Sci; 1993; 30(1):1-28. PubMed ID: 8489735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
    Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
    Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic classification of non-Hodgkin's lymphomas: current status.
    Seligmann M; Brouet JC; Preud'homme JL
    Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical studies of leukemic non-Hodgkin's lymphoma. II. Clinicopathological aspects and prognostic factors].
    Takenaka T; Kimura K; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K
    Nihon Ketsueki Gakkai Zasshi; 1983 Nov; 46(6):1256-65. PubMed ID: 6369857
    [No Abstract]   [Full Text] [Related]  

  • 35. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
    Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
    Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Classification of malignant lymphomas of the neck: combined morphological, immunocytological, serological and tissues culture studies (author's transl)].
    Sesterhenn K; Krüger GR; Uhlmann C; Ablashi DV; Samii H; Wustrow F; Fischer R
    Laryngol Rhinol Otol (Stuttg); 1976 Oct; 55(10):823-32. PubMed ID: 136561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curability of non-Hodgkin's lymphomas.
    McKelvey EM; Moon TE
    Cancer Treat Rep; 1977 Sep; 61(6):1185-90. PubMed ID: 332352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.